|
1
|
Brain masculinization requires androgen receptor function.
|
Proc Natl Acad Sci U S A
|
2004
|
1.51
|
|
2
|
Effects of docosahexaenoic Acid on the endothelial function in patients with coronary artery disease.
|
J Atheroscler Thromb
|
2014
|
1.45
|
|
3
|
High plasma heparin cofactor II activity is associated with reduced incidence of in-stent restenosis after percutaneous coronary intervention.
|
Circulation
|
2004
|
1.27
|
|
4
|
Androgen-androgen receptor system protects against angiotensin II-induced vascular remodeling.
|
Endocrinology
|
2009
|
0.98
|
|
5
|
Chondromodulin I is a bone remodeling factor.
|
Mol Cell Biol
|
2003
|
0.97
|
|
6
|
Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency.
|
Circ Res
|
2007
|
0.97
|
|
7
|
Effect of aspirin treatment on serum concentrations of lipoprotein(a) in patients with atherosclerotic diseases.
|
Clin Chem
|
2002
|
0.96
|
|
8
|
Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
|
Hypertension
|
2010
|
0.94
|
|
9
|
Androgen receptor counteracts Doxorubicin-induced cardiotoxicity in male mice.
|
Mol Endocrinol
|
2010
|
0.94
|
|
10
|
Deferoxamine promotes angiogenesis via the activation of vascular endothelial cell function.
|
Atherosclerosis
|
2011
|
0.90
|
|
11
|
Ezetimibe ameliorates metabolic disorders and microalbuminuria in patients with hypercholesterolemia.
|
J Atheroscler Thromb
|
2010
|
0.90
|
|
12
|
Infective endocarditis caused by lactobacillus.
|
Intern Med
|
2008
|
0.89
|
|
13
|
Ezetimibe monotherapy ameliorates vascular function in patients with hypercholesterolemia through decreasing oxidative stress.
|
J Atheroscler Thromb
|
2011
|
0.88
|
|
14
|
Heparin cofactor II, a serine protease inhibitor, promotes angiogenesis via activation of the AMP-activated protein kinase-endothelial nitric-oxide synthase signaling pathway.
|
J Biol Chem
|
2012
|
0.88
|
|
15
|
Carbohydrate-to-insulin ratio is estimated from 300-400 divided by total daily insulin dose in type 1 diabetes patients who use the insulin pump.
|
Diabetes Technol Ther
|
2012
|
0.85
|
|
16
|
High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension.
|
Hypertens Res
|
2010
|
0.84
|
|
17
|
Dehydroepiandrosterone sulfate is inversely associated with sex-dependent diverse carotid atherosclerosis regardless of endothelial function.
|
Atherosclerosis
|
2010
|
0.84
|
|
18
|
Inhibition of thrombin action ameliorates insulin resistance in type 2 diabetic db/db mice.
|
Endocrinology
|
2009
|
0.83
|
|
19
|
Diabetic conditions differentially affect the endothelial function, arterial stiffness and carotid atherosclerosis.
|
J Atheroscler Thromb
|
2014
|
0.81
|
|
20
|
Role of hypoxia-inducible factor 1alpha in T cells as a negative regulator in development of vascular remodeling.
|
Arterioscler Thromb Vasc Biol
|
2009
|
0.81
|
|
21
|
Effects of androgens on cardiovascular remodeling.
|
J Endocrinol
|
2012
|
0.80
|
|
22
|
Nitrosonifedipine ameliorates angiotensin II-induced vascular remodeling via antioxidative effects.
|
Naunyn Schmiedebergs Arch Pharmacol
|
2012
|
0.79
|
|
23
|
Bosentan ameliorated exercise-induced pulmonary arterial hypertension complicated with systemic sclerosis.
|
Intern Med
|
2010
|
0.78
|
|
24
|
Vascular smooth muscle cell proliferation is dependent upon upregulation of mitochondrial transcription factor A (mtTFA) expression in injured rat carotid artery.
|
Atherosclerosis
|
2005
|
0.78
|
|
25
|
Activation of peroxisome proliferator-activated receptor α in megakaryocytes reduces platelet-derived growth factor-BB in platelets.
|
J Atheroscler Thromb
|
2010
|
0.77
|
|
26
|
Improvement of cardiac diastolic function and prognosis after autologous peripheral blood stem cell transplantation in AL cardiac amyloidosis.
|
Intern Med
|
2007
|
0.77
|
|
27
|
Decrease in plasma brain natriuretic peptide level in the early phase after the start of carvedilol therapy is a novel predictor of long-term outcome in patients with chronic heart failure.
|
Acta Cardiol
|
2009
|
0.77
|
|
28
|
High serum parathyroid hormone and calcium are risk factors for hypertension in Japanese patients.
|
Endocr J
|
2014
|
0.76
|
|
29
|
Bovine milk-derived lactoferrin exerts proangiogenic effects in an Src-Akt-eNOS-dependent manner in response to ischemia.
|
J Cardiovasc Pharmacol
|
2013
|
0.76
|
|
30
|
Non-invasive Measurement of Skin Autofluorescence as a Beneficial Surrogate Marker for Atherosclerosis in Patients with Type 2 Diabetes.
|
J Med Invest
|
2015
|
0.76
|
|
31
|
Isolated high-molecular-weight kininogen deficiency: a novel frameshift mutation in exon 10.
|
Blood
|
2007
|
0.75
|
|
32
|
Roles of the Androgen - Androgen Receptor System in Vascular Angiogenesis.
|
J Atheroscler Thromb
|
2015
|
0.75
|
|
33
|
Aspirin inhibits thrombin action on endothelial cells via up-regulation of aminopeptidase N/CD13 expression.
|
Atherosclerosis
|
2005
|
0.75
|
|
34
|
Fibrinogen Tokushima II: a new case of congenital dysfibrinogenemia with a γ methionine-310 to threonine substitution.
|
Int J Hematol
|
2012
|
0.75
|
|
35
|
Intra-vascular ultrasound findings of diffuse coronary atherosclerotic change in systemic lupus erythematosus with secondary antiphospholipid syndrome.
|
Circ J
|
2006
|
0.75
|
|
36
|
Bosentan improves systemic sclerosis-related peripheral circulation insufficiency.
|
Int J Cardiol
|
2011
|
0.75
|
|
37
|
Factor VII Tokushima: the first case of factor VII Cys22Gly with the development of myocardial infarction in the proband receiving recombinant factor VIIa replacement therapy.
|
Blood Coagul Fibrinolysis
|
2015
|
0.75
|
|
38
|
Antithrombin-p.Ala416Pro: the second reported case in Japan.
|
Intern Med
|
2014
|
0.75
|